Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study.
Spiering W, Williams B, Van der Heyden J, van Kleef M, Lo R, Versmissen J, Moelker A, Kroon A, Reuter H, Ansel G, Stone GW, Bates M; CALM-FIM_EUR investigators.
Spiering W, et al.
Lancet. 2017 Dec 16;390(10113):2655-2661. doi: 10.1016/S0140-6736(17)32337-1. Epub 2017 Sep 1.
Lancet. 2017.
PMID: 28870716
Clinical Trial.